Oregon Medical Board Information
Statement of Philosophy: Pain Management
ORS 677.474: Administration of controlled substance for pain allowed; exceptions
OAR 847-015-0030: Written Notice Disclosing the Material Risks Associated with Prescribed or Administered Controlled Substance for the Treatment of “Intractable Pain”
The Material Risk Notice form
OAR 847-008-0075: Mandatory Pain Management Education
Continuing Education Requirements for Pain Management
Continuing Education Opportunities
Oregon Pain Management Commission one-hour pain management CME (required) – PDF and Word versions of the module are available. The site includes links to additional pain courses and a mailing list to receive direct information.
Extended-Release and Long-Acting Opioids: Assessing Risks, Safe Prescribing – The Federation of State Medical Boards' free, online CME Risk Evaluation and Mitigation Strategy (REMS) activity provides prescribers with training and educational resources.
COPE (Collaborative Opioid Prescribing Education) Course – The University of Washington's free, online, interactive course promotes a shared decision-making approach between providers and patients.
Eastern Oregon Summit to Reduce Rx Abuse (April 24, 2015) – The Oregon Coalition for the Responsible Use of Meds (OrCRM) will bring togehter representatives from the medical community, pharmacies, health systems, and others to create community level action plans to reduce Rx abuse in Eastern Oregon and create momentum for statewide change.
Oregon Health & Science University published downloadable Guidelines for Safe Chronic Opioid Therapy Prescribing for Patients with Chronic Non-Cancer Pain. The guidelines address topics such as health, pain and functional assessments, management of opioid risk and what to do when diversion is suspected.
In April 2014, the Oregon Medical Group published Primary Care Guidelines for Chronic Opioid Prescribing. The Guidelines describe essential elements when prescribing opioids for the treatment of chronic pain.
The Oregon Prescription Drug Monitoring Program (PDMP) is a database that allows prescribers of controlled substances to access a patient’s prescription history.
The Opioid Prescriber's Group of Southern Oregon, a diverse group of health care professionals from Jackson and Josephine Counties, provides resources for understanding, evaluation, and application of best practices for the treatment of complex chronic pain.
In July 2013, the Federation of State Medical Boards (FSMB) adopted a new Model Policy for the Use of Opioid Analgesics in the Treatment of Chronic Pain. The model policy provides informational guidelines for determining if opioid analgesics are appropriate and compliant with state and federal laws and regulations. In addition, the FSMB offers both a paperback electronic version of its publication, Responsible Opioid Prescribing: A Clinician’s Guide. The FSMB also provides numerous other resources such as pain and function assessment tools, treatment consensus statements, guides and guidelines, federal regulations and other sites of interest on its Pain Resources page.
In 2010, the Washington State Agency Medical Directors Group published the Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain (CNCP). The Guideline addresses initiating, transitioning and maintaining opioids for chronic non-cancer pain patients and optimizing treatment through various methods.
The National Opioid Use Guideline Group (NOUGG), a group based from the Federation of Medical Regulatory Authorities of Canada, has established the Canadian Guideline for Safe and Effective Use of Opioid for Chronic Non-Cancer Pain and offers applications for Android and iPhones and an Opioid Manager site.